Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  IDEXX Laboratories, Inc.    IDXX

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
The feature you requested does not exist. However, we suggest the following feature:

IDEXX LABORATORIES : IDXX) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/16/2016 | 09:20pm CET
IDEXX LABORATORIES, INC. (IDXX) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On November 9, 2016, IDEXX Laboratories, Inc. (the "Company") announced that Michael Williams, Ph.D., Executive Vice President, will be leaving the Company in February 2017 and is stepping down from his current position effective November 9, 2016. Dr. Williams will remain employed at the Company until February 28, 2017 in order to assist in the transition of his responsibilities. In connection with this, the Company agreed to pay Dr. Williams a lump sum of $460,000, the amount of $450,000 in 26 bi-weekly installments, and certain other benefits, all in consideration of Dr. Williams's agreement to certain non-competition and non-solicitation obligations and a standard release of claims.

 


About IDEXX LABORATORIES, INC. (IDXX)


The post IDEXX LABORATORIES, INC. (IDXX) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers appeared first on Market Exclusive.

]]>

© Market Exclusive 2016, source Market Exclusive

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on IDEXX LABORATORIES, INC.
11/16 IDEXX LABORATORIES : IDXX) Files An 8-K Departure of Directors or Certain Office..
11/15 IDEXX LABORATORIES INC /DE : Change in Directors or Principal Officers (form 8-K..
11/15 IDEXX LABORATORIES : Announces Departure of Executive Vice President Michael Wil..
11/14 IDEXX LABORATORIES : Welcomes Healthcare Technology Veteran Pat Venters as Chief..
11/01 IDEXX LABORATORIES : DE Management's Discussion and Analysis of Financial Condit..
11/01 IDEXX LABORATORIES : beats 3Q profit forecasts
11/01 IDEXX LABORATORIES INC /DE : Results of Operations and Financial Condition, Fina..
11/01 IDEXX LABORATORIES : Announces Third Quarter Results
10/28 IDEXX LABORATORIES : to Present at Credit Suisse Healthcare Conference
10/27IDEXX LABORATORIES, INC. : quaterly earnings release
More news
Sector news : Veterinary Medical Equipment & Supplies
12/08 MEDTRONIC : China says fines Medtronic local unit 118.5 million yuan for price f..
11/22DJMEDTRONIC : Cuts Guidance on Sluggish Revenue
11/22DJMEDTRONIC : Cuts Guidance on Sluggish Revenue -- 2nd Update
11/22DJMEDTRONIC : Cuts Guidance on Sluggish Revenue
11/15 EXCLUSIVE : EU regulators seen clearing $25 billion Abbott, St Jude deal
More sector news : Veterinary Medical Equipment & Supplies
News from SeekingAlpha
11/30 Tracking Ruane, Cunniff & Goldfarb's Portfolio - Q3 2016 Update
11/17 Buy Ulta Salon At $240 - Cramer's Lightning Round (11/16/16)
11/01 IDEXX Laboratories (IDXX) Q3 2016 Results - Earnings Call Transcript
11/01 IDEXX Laboratories Q3 revenues up 10%; earnings up 28%; updates guidance; sha..
11/01 IDEXX Laboratories beats by $0.02, revenue in-line
Advertisement
Financials ($)
Sales 2016 1 769 M
EBIT 2016 342 M
Net income 2016 216 M
Debt 2016 685 M
Yield 2016 -
P/E ratio 2016 49,70
P/E ratio 2017 41,65
EV / Sales 2016 6,38x
EV / Sales 2017 5,70x
Capitalization 10 601 M
More Financials
Chart IDEXX LABORATORIES, INC.
Duration : Period :
IDEXX Laboratories, Inc. Technical Analysis Chart | IDXX | US45168D1046 | 4-Traders
Full-screen chart
Technical analysis trends IDEXX LABORATORIE...
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 10
Average target price 121 $
Spread / Average Target 2,0%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Jonathan W. Ayers Chairman, President & Chief Executive Officer
Brian P. McKeon Chief Financial Officer, Treasurer & Executive VP
Rebecca M. Henderson Independent Director
Thomas Craig Independent Director
Barry C. Johnson Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
IDEXX LABORATORIES, IN..62.15%10 601
MEDTRONIC PLC-4.64%100 713
STRYKER CORPORATION25.35%43 624
BECTON DICKINSON AND C..6.20%35 353
BAXTER INTERNATIONAL I..17.54%24 389
ESSILOR INTL.-9.87%23 878
More Results